evolution of targeted therapy in advanced nsclc
Published 4 years ago • 183 plays • Length 4:23Download video MP4
Download video MP3
Similar videos
-
4:05
the evolution of alk/ros1-targeted therapy in nsclc
-
2:12
dr. pennell on the evolution of targeted treatment in nsclc
-
1:08:39
ecological interactions drive evolution of targeted therapy resistance in cancer
-
4:55
evolution of therapy in lung cancer - 2022 program: targeted therapies forum
-
30:32
2023 best of lung: targeted therapies in lung cancer
-
5:00
evolution of targeted therapy in mrcc
-
1:18
dr. lopategui on the evolution of targeted therapies in nsclc
-
1:06:18
breath of equityfostering inclusive lung cancer care for all
-
3:14
advancements of targeted therapy for egfr mutations in nsclc
-
5:29
development of kras g12c-targeted therapy in nsclc
-
25:26
locally advanced nsclc: combination therapy with targeted and immunotherapy agents
-
2:22
dr. pennell on the evolution of targeting her2 in lung cancer
-
4:08
targeted therapies in lung cancer
-
4:41
history of kras testing in advanced nsclc
-
59:19
precision oncology in early-stage lung cancer, with adjuvant egfr-targeted therapy leading the way
-
58:27
addressing key targets in advanced nsclc: her2-, her3-, and trop2-targeted therapies
-
33:52
keynote lecture: targeted therapies in lung cancer 2.0 – advances and promises
-
12:14
collaboration with oncology and evolution of targeted therapies
-
44:56
advanced nsclc: refining clinical pathways in the rapidly evolving therapeutic landscape